Several lots of intravenous and subcutaneous immune globulin have been voluntarily withdrawn by the manufacturers as a precautionary measure due to increased reports of allergic/hypersensitivity type ...
Do not mix with IGIV products from other manufacturers. Not compatible with saline; if dilution required, may be diluted with 5% D5/W. Contents of vials may be pooled under asceptic conditions ...
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease. The purpose of this study is to determine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results